Abstract: The present invention relates to antibody conjugates, and methods of manufacturing the same. In particular, the present invention relates to a conjugate comprising an antibody, a linker and at least one active agent, wherein: the linker connects the at least one active agent(s) to the antibody; ii) the linker is attached to the antibody through 5 to 8 independent covalent bonds; and iii) each covalent bond between the linker and the antibody is formed from the reaction between a sulfur atom on the antibody and a functional group on the linker.
| # | Name | Date |
|---|---|---|
| 1 | 202417005798-STATEMENT OF UNDERTAKING (FORM 3) [29-01-2024(online)].pdf | 2024-01-29 |
| 3 | 202417005798-Sequence Listing in PDF [29-01-2024(online)].pdf | 2024-01-29 |
| 4 | 202417005798-FORM 1 [29-01-2024(online)].pdf | 2024-01-29 |
| 5 | 202417005798-DRAWINGS [29-01-2024(online)].pdf | 2024-01-29 |
| 6 | 202417005798-DECLARATION OF INVENTORSHIP (FORM 5) [29-01-2024(online)].pdf | 2024-01-29 |
| 7 | 202417005798-COMPLETE SPECIFICATION [29-01-2024(online)].pdf | 2024-01-29 |
| 8 | 202417005798-FORM-26 [12-03-2024(online)].pdf | 2024-03-12 |
| 9 | 202417005798-Proof of Right [18-03-2024(online)].pdf | 2024-03-18 |
| 10 | 202417005798-FORM 3 [18-03-2024(online)].pdf | 2024-03-18 |
| 11 | 202417005798-RELEVANT DOCUMENTS [17-04-2025(online)].pdf | 2025-04-17 |
| 12 | 202417005798-POA [17-04-2025(online)].pdf | 2025-04-17 |
| 13 | 202417005798-FORM 13 [17-04-2025(online)].pdf | 2025-04-17 |
| 14 | 202417005798-FORM-26 [25-04-2025(online)].pdf | 2025-04-25 |
| 15 | 202417005798-FORM 18 [14-07-2025(online)].pdf | 2025-07-14 |